Pharma
Follow
Find
42.5K views | +3 today
 
Scooped by Andrew Spong
onto Pharma
Scoop.it!

New ways of seeing, new ways of saying: a New Year for pharma

New ways of seeing, new ways of saying: a New Year for pharma | Pharma | Scoop.it

Andrew Spong (@andrewspong) writes:

 

The familiar rituals of festive celebration can be a comfort to many, and prudent hosts remember that such occasions are not a time for innovation. Family, friends and guests are more likely to enjoy the shared pleasures of participating in a ritual’s traditions than they are to be craving diversion from its norms.

 

However, beyond a certain point the appeal of the familiar can quickly wane. Not only can we have a surfeit of convention; we can also become thoroughly nauseated by it.

 

Reviewing some of the customary ‘New Year’s predictions for pharma’ posts on returning to my desk this week, I felt more than a little queasy (this post by Digitally Sick colleague Alex Butler being a notable exception).

 

Unlike the celebrations that precede it, the New Year is a time to take a fresh look at the problems that confront us, not merely to resume the worn-out discussions of the preceding twelve months.

 

It is a time to acknowledge that the act of asking the same question in the same manner that failed to produce an answer previously is unlikely to deliver a positive outcome if restated. Let us hear no more of the ‘perils’ of adverse event reporting, of the supposed indeterminacy of a return on digital investment, of regulatory lacunae, or any of the other hackneyed subjects that provide what Joyce in another context described as the ‘happy hunting ground of all minds that have lost their balance.’

 

It is not easy for an industry such as pharma to refashion its self-image.

However, this is not merely a corollary of its traditional conservatism and aversion to risk. It is also a consequence of the fact that the agencies, analysts and pundits that swarm around pharma can serve (not always unwittingly) to conceal rather than reveal opportunities, diverting its gaze with gadgets, dashboards and statistics ‘in order not to look at’ the new possibilities that are in reality open to it.

 

New ideas are rendered ‘invisible because they are rejected in principle[...] and that is why their fleeting presence when it does occur goes unperceived’. Even in a regulated industry, the majority of ‘limits are internal‘ as a consequence of its having ’carried its outside inside it’.

 

In 2013, the pharma industry needs to cultivate a newly informed gaze, and new ways of seeing require new ways of saying in order to describe them.

 

In 2013, the industry should challenge itself as well as its service providers not to use the language that is reached for so lazily by so many without going to the trouble of interrogating its enduring relevance or meaning.

In 2013, pharma and healthcare concerns can choose either to continue to passively endure the repetitious drone of familiar voices who have little new to contribute to its advancement, or to actively emulate and aim to exceed the softly spoken, understated achievements of peers such as Sanofi and GE Healthcare who have quietly gone about their business redefining elements of clinician education and providing examples of new ways of thinking about what patient advocacy and support might look like in online environments.

The choice is theirs.

 

Health and happiness to you and yours in 2013.

 

Citations: Louis Althusser & Étienne Balibar, Reading Capital (1968; London: Verso, 2009) pp. 27-28

more...
No comment yet.
Pharma
Curating the writing of pharma's digital prescription
Curated by Andrew Spong
Your new post is loading...
Your new post is loading...
Rescooped by Andrew Spong from Patient
Scoop.it!

Healthcare is getting better. Let's talk about what you can do to make it even better, faster.

Healthcare is getting better. Let's talk about what you can do to make it even better, faster. | Pharma | Scoop.it

Click on the link above to contact Andrew Spong, Managing Director, STweM Ltd.

more...
Scooped by Andrew Spong
Scoop.it!

The five Ws of health message design

The five Ws of health message design | Pharma | Scoop.it

Click here to edit the title

Andrew Spong's insight:

Excerpted from the World Innovation Summit for Health 2015 report (p.13), available as a free download (without a data scrape) here:

 

http://dpnfts5nbrdps.cloudfront.net/app/media/1426

 

See also #WISH2015

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Digital health in the EU: moving beyond the pill

Digital health in the EU: moving beyond the pill | Pharma | Scoop.it
mHealth is becoming a driving force in the life sciences on both sides of the Atlantic. This contributed commentary examines how the industry is developing in Europe.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Patients will trade more personal health info with pharma for more relevant services

Patients will trade more personal health info with pharma for more relevant services | Pharma | Scoop.it
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

A nanotech application that keeps bacteria from sticking to surfaces

A nanotech application that keeps bacteria from sticking to surfaces | Pharma | Scoop.it

A nanotechnology that exerts a repulsive force on bacterial cells and prevents attachment and biofilm formation.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Thingful: a search engine for the Internet of Things

Thingful: a search engine for the Internet of Things | Pharma | Scoop.it
Thingful is a search engine for the Internet of Things, providing a geographical index of where things are, who owns them, and how and why they are used.
more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

3D printed meds to be made by pharma and hospitals within five years, and by the public within 10

3D printed meds to be made by pharma and hospitals within five years, and by the public within 10 | Pharma | Scoop.it

UCLan project predicts 3D printed medicine techniques will be used by pharmaceutical firms and hospitals within five years and by the public within a decade.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

On pharma, authenticity, and the expectations of health consumers

On pharma, authenticity, and the expectations of health consumers | Pharma | Scoop.it

Today, consumers of healthcare want authenticity when researching health information, but that means a lot of things to different people.

Andrew Spong's insight:

Rich Meyer makes five compelling points in this concise and useful article. Take a couple of minutes to review it, and reflect on his suggestions (NB one is only relevant to DTC)

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Pharma companies have many apps, relatively few downloads

Pharma companies have many apps, relatively few downloads | Pharma | Scoop.it
more...
Justin Hipps, MBA's curator insight, October 28, 2014 4:39 PM

Read More Here: http://mobihealthnews.com/37637/report-pharma-companies-have-many-apps-relatively-few-downloads/ ;

Tanya Kerr's curator insight, January 23, 6:27 PM

An interesting review of the Apps currently produced by pharmaceutical companies and why they are currently widely downloaded /used are they too specific?

Scooped by Andrew Spong
Scoop.it!

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences

Involving people with lived experience: time to choose, because you can't support this, *and* still attend digital pharma conferences | Pharma | Scoop.it

"A patient and carer viewpoint [will be] represented in every single session and workshop throughout the day, [and] we will be involving people with lived experience in other areas across the conference, including as speakers, chairs and mentors."

Andrew Spong's insight:

There are many reasons to want to attend healthcare conferences.

 

However, when there are options like this available, it's verging on reprehensible for anyone in the pharmaceutical industry to continue to support the lame duck, 'Usual Suspect' digital pharma conferences that reiterate themselves year after year, celebrating their repetition as though having done the same thing for eight years were an achievement rather than an embarrassment.

 

If you're serious about putting the patient at the centre of what you do, you *have* to go to conferences that put the patient at the centre of their programme -- not ones that pay lip service to 'patient engagement' in the absence of their eponymous subjects, and brazenly focus on patients as 'targets' and 'opportunities' rather than as people.


It's time to choose.


Do the right thing.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Mobile: transcending borders, rendering regulatory frameworks impotent

Mobile: transcending borders, rendering regulatory frameworks impotent | Pharma | Scoop.it

By 2017, 85% of the world’s population is expected to be covered by a commercial mobile signal.

 

Transcending state borders, mobile apps bring about a lot interesting questions for anyone studying regulatory frameworks and state-based policy....

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014

Six finalists announced in the 'Digital pharmaceutical company of the year' category of the PM Society Digital Media Awards 2014 | Pharma | Scoop.it

Bayer, Boehringer Ingelheim, Genentech (Roche), GSK, Novartis and Sanofi have been shortlisted as finalists in the 'Digital pharmaceutical company of the year' category of this year's PM Society Digital Media Awards

Andrew Spong's insight:

I was pleased that STweM was able to work with our partners Symplur to compile the data behind this year's 'Digital pharmaceutical company of the year' category.

 

Results were derived by collating all tweets published in 2013 using the top ten hashtags in Symplur's Healthcare Hashtag Project associated with ten leading causes of mortality.

 

The top pharma companies within each disease area were identified according to the frequency with which they were mentioned.

 

The final results were determined by subsequently identifying those companies which featured most often in each category, weighting by rank, and ordering accordingly.


The winner will be announced on 25 September. I was kindly asked to present the award by the PM Society, but will be out of the country. PM Society co-chair Carwyn Jones has graciously offered to do the honours in my absence.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age

Patients, pharma, conferences, and the thorny question of 'Return On Investment' in the social age | Pharma | Scoop.it

The evergreen question of what constitutes 'ROI' for pharma in being seen to actively participate in the healthcare conversation on the social web around conference is addressed from many angles in this @CancerGeek article, which reflects on Thomas Lee of Symplur's recent MedX presentation.

 

Do also be sure to read the productive exchanges in the comments.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Building online health communities: the journey from virtual to reality

A video from this week's #hccmty event

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Communicating health messages: assess, do, describe

Communicating health messages: assess, do, describe | Pharma | Scoop.it

Click here to edit the title

Andrew Spong's insight:

Excerpted from the World Innovation Summit for Health 2015 report (pp.14-15), available as a free download (without a data scrape) here:

 

http://dpnfts5nbrdps.cloudfront.net/app/media/1426

 

See also #WISH2015

more...
Sunnie Southern's curator insight, February 20, 2:15 PM

Appreciate this insight graphic.  If we expect patient outcomes to improve with education then we need to be more strategic about our approach to how we educate and what we educate with! Thanks Andrew!

Scooped by Andrew Spong
Scoop.it!

What would Samsung buying BlackBerry mean for healthcare?

What would Samsung buying BlackBerry mean for healthcare? | Pharma | Scoop.it
Andrew Spong's insight:

Tapping BlackBerry as part of a push into hospitals is a natural fit for Samsung, particularly because Apple just raised the stakes of the enterprise mobility game by inking a high-profile partnership with IBM, and healthcare was a big part of that push.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

68% of patients prefer pharma companies to interact with them through digital channels

68% of patients prefer pharma companies to interact with them through digital channels | Pharma | Scoop.it
more...
Helen Adams's curator insight, January 23, 4:33 AM

Only 68%!

Tanya Kerr's curator insight, January 23, 6:10 PM
This is a survey of US patients but the trend still has relevance to other markets
Scooped by Andrew Spong
Scoop.it!

Five new year's resolutions for digital health

Five new year's resolutions for digital health | Pharma | Scoop.it

Reforming the perverse and inhuman world of digital health

more...
XPert Patient's comment, December 22, 2014 1:52 PM
A very thought provoking article! I am of the view that 2015 will be the "Year of the Patient" on the social web. Patients are able to tune out of the hype and the "money-driven digital health orthodoxies." However, I do want to tune into news about genetic and genomic technologies which are revolutionising prognosis and treatment.

Regardless of digital health, we must always remember that medicine is a vocation. My late uncle who passed away this year, was a general surgeon working at the height of the Troubles in Northern Ireland. He saved countless lives in the operating theatres as staff attempted to hold the line under extraordinary strain. He frequently worked through day and night to aid victims of the latest shooting or bomb blast. He retired early from Gaelic Football to protect his "hands" - a surgeon of the highest rank, he was renowned for skill and speed. The local press in a tribute to him said " John O'Neill always led the field in things that really matter."

Let's hope that we all too can "hold the line" by standing up for what is right on the social web & just like my late uncle - lead the field in things that really matter in 2015.
Scooped by Andrew Spong
Scoop.it!

Patient engagement: the core of effective population health management

Engaging patients is not simply about providing them with basic health information, but going beyond this to provide information that is truly relevant and of use to them.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

The mobile health entrepreneur: an endangered species?

The mobile health entrepreneur: an endangered species? | Pharma | Scoop.it

What can we learn about the future of mobile health applications by considering the evolution of the website over the last two decades?

more...
Art Jones's curator insight, November 12, 2014 12:37 PM

This is a thought provoking question. When you look at the history of website design and how easy it is to design a modern website, it is reasonable to expect mHealth APS will take the same accelerated path.


One day APS may develop themselves to meet each of our unique mHealth requirements.


 Does The Future = Personalized mhealth APS ?

Scooped by Andrew Spong
Scoop.it!

Millennials want to know how companies are solving social problems

Millennials want to know how companies are solving social problems | Pharma | Scoop.it
The millennial generation care less about corporate philanthropy and big cash donations, and more about how corporations are solving social problems.
Andrew Spong's insight:

It's so disappointing to see this important issue addressed within the context of 'corporate social responsibility'.

 

CSR is a PR-driven locked box within which social good is permitted to be pursued in limited contexts whilst the rest of an organisation maintains destructive practices unchecked.

 

Companies committed to reforming themselves should begin by dissolving their CSR units.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Five steps to building successful digital health interventions

Five steps to building successful digital health interventions | Pharma | Scoop.it

Context. Interoperability. Physician (and patient, presumably) 'engagement'. Evidence. Scale.

Andrew Spong's insight:

All factors worth bearing in mind, certainly, but in a sense this article is simply a reminder that every potential intervention needs to be considered on its merits, and that potentially successful solutions reside in the middle of a complex set of interrelations.

 

Overlooking any one of them is likely to consign your efforts to failure.

 

Oh, and good luck with 'interoperability'.

 

Who can really be said to have 'cracked' this yet, beyond marketing spin?

 

A 'Gordian Knot' solution that addresses the difficulties of legacy providers' EHR interoperability by severing ties with them altogether, and taking a consumer-led view by using the patient's own healthcare records seems only a generation or two of devices away at this point.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Six ways social media affects your clinical trial - whether you like it, or not

Six ways social media affects your clinical trial - whether you like it, or not | Pharma | Scoop.it

Transparency; recruitment; information sharing; advocacy; learning; support.

 

In short, pretty much everything has changed -- and there's both good and bad, from multiple, and often highly challenging perspectives.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes"

"Social media and real-time support can be done by pharma, and it’s being done right before your eyes" | Pharma | Scoop.it
Andrew Spong's insight:

Kai Gait, Global Digital Director, GSK, keeping it real, as usual.

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

Astellas hosts an app-focused Innovation Challenge in association with New Scientist

Astellas hosts an app-focused Innovation Challenge in association with New Scientist | Pharma | Scoop.it

Astellas invites participants to 'Come up with an innovative app for healthy living that impresses [their] judges and your idea could become a reality!'

Andrew Spong's insight:

A positive, progressive idea. Great to see Astellas teaming up with New Scientist for this initiative, too

more...
No comment yet.
Scooped by Andrew Spong
Scoop.it!

An overview of pharma's health accelerator initiatives and startup support

An overview of pharma's health accelerator initiatives and startup support | Pharma | Scoop.it

Merck, Bayer, GSK, Novartis, Janssen and more are all running digital health accelerator support programmes for startups

more...
Jim Murphy's curator insight, September 12, 2014 8:53 AM

Incubating only works if the seeds get planted.  When these companies actually bring these solutions to market then it will be more than a branding gimmick.